Chimin Health Management

Chimin Health Management is a leading Chinese pharmaceutical and healthcare enterprise with a diversified portfolio spanning pharmaceuticals, medical devices, and hospital/medical services. It has several approved products in China including ligustrazine phosphate for ischemic stroke and Jimaitong Tablets for hypertension. The company is also one of China's largest producers of non-PVC soft bag infusions and related disposable medical devices. It operates multiple production bases in China and Spain, owns or controls nine subsidiaries including Boao International Hospital in Hainan's Lecheng Medical Tourism Pilot Zone, and maintains high-tech enterprise status with over 50 national patents[1][2][5][6].